Ryan Griffin

Tight End

Age: 31
Free Agency: 2023 (UFA)
Accrued Seasons: 8
  • 2021 Salary Cap Charge: $2,740,588 (1.31% of cap)
  • 2021 Cash Payout: $2,940,000 (1.52% of spending)
  • 2021 Cash to Cap Ratio: 1.07
  • Contract Value: $6,028,471 ($3,040,824 APY)
  • Fully Guaranteed Money: $450,000
  • Contract Ranking: 29/176 at TE

Current Contract

(SFA, signed 2021)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202131$2,541,176$199,412$452,000$450,000$2,740,5881.3%
202232$2,636,471$199,412$452,000$0$3,287,8831.6%
Total$5,177,647$398,824$904,000$450,000$6,028,471

Contract Notes

Ryan Griffin signed a three year, $9.55 million contract extension with the Jets on November 23, 2019. Griffin received $4.3 million in guarantees and can earn up to $1.5 million in additional incentives.

Cash Flows

- fully earned money
- unearned or partially earned money
$3M
$6.1M
20212022
Cash Due$2,940,000$3,088,471
Running Cash$2,940,000$6,028,471
Career Earnings: $13,303,930
Career APY: $1,662,991
Potential Earnings: $19,332,401
Total Guarantees: $8,082,503
Largest Cash Payment: $3,878,823 (2020)
Largest Cap Number: $3,500,000 (2017)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
TexansDraftedExpired20134$2,238,680$559,670$78,680$2,238,680100.0%$559,670
TexansUFATerminated20173$9,000,000$3,000,000$3,225,000$6,130,25068.1%$3,065,125
JetsSFARenegotiated20191$1,125,000$1,125,000$0$00.0%$0
JetsExtensionTerminated20193$9,550,000$3,183,333$4,328,823$4,935,00051.7%$2,467,500
JetsSFAActive20212$6,028,471$3,040,824$450,000$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Texans6$8,368,930$1,394,822$8,426,1800.0%$00.0%
Jets2$4,935,000$2,467,500$4,178,7500.0%$1,000,0000.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2013Texans$405,000$19,670$0$0$0$0$424,6700.3%$483,680
2014Texans$495,000$19,670$0$0$0$0$514,6700.4%$495,000
2015Texans$585,000$19,670$0$0$0$0$604,6700.4%$585,000
2016Texans$675,000$19,670$0$0$0$0$694,6700.4%$675,000
2017Texans$875,000$0$2,350,000$275,000$0$3,225,000$3,500,0002.0%$3,442,750
2018Texans$2,250,000$0$0$500,000$0$0$2,687,5001.4%$2,687,500
2019Jets$805,000$0$0$125,000$0$0$1,056,1770.5%$1,056,177
2020Jets$1,160,000$500,000$918,823$300,000$300,000$2,378,823$3,122,5731.5%$3,878,823
2021Jets$2,541,176$199,412$0$452,000$0$450,000$2,740,5881.3%$2,940,000
2022Jets$2,636,471$199,412$0$452,000$0$0$3,287,8831.6%$3,088,471
Total$12,427,647$977,504$3,268,823$2,104,000$300,000$6,053,823$18,633,401$19,332,401
Dead Money History
TeamYearCap ChargeCash Paid
Jets2021$500,000$0
Jets2022$500,000$0
Total$1,000,000$0

Statistics

YearGames PlayedGames MissedSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2013150132.3%53.5%000.001924412.8100
2014160030.2%31.5%000.0010919.1100
201598029.6%5.9%000.002025112.6200
2016160045.3%14.8%000.00504428.8211
201778131.7%6.5%000.001315812.2100
2018140267.9%30.0%000.002430512.7000
2019123065.5%35.2%000.00343209.4500
2020150039.5%47.5%000.009869.6000
202150063.1%50.7%000.008496.1000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$2,859,000$3,040,824
Injury Adjusted$2,859,000$3,040,824
test
OTC Valuation $2.1M $4.3M $6.4M $8.5M $10.7M APY $2.5M $5.0M $7.5M $10.0M $12.5M $7,477,000 $6,016,667

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.